With a potential first-in-class product in dermatology nearing launch, a robust real-world evidence (RWE) generation plan is needed to support the product launch and marketing strategy. The objective of building a 5-year RWE business plan will provide support to other products and indications in the company’s dermatology pipeline

APPERTURE excels in brand and payor strategy, global pricing and market access, value communication, and innovative outcomes & evidence strategies.